Pubblicazioni

Safety of obinutuzumab alone or combined with chemotherapy for previously untreated or relapsed/refractory chronic lymphocytic leukemia in the Phase 3b GREEN study

2018 - HAEMATOLOGICA

Leblond, V; Aktan, M; Ferra Coll CM, ; Dartigeas, C; Kisro, J; Montillo, M; Raposo, J; Merot, Jl; Robson, S; Gresko, E; Bosch, F; Stilgenbauer, S; FoÃ , R